Stephen P. Squinto, EVP, Head of R&D at ALEXION PHARMACEUTICALS INC (ALXN), sold 2,572 shares at $95.66 ($246K) on 2013-02-04, disclosed to the SEC on 2013-02-06.
Seasonal sale ($246k) by EVP, Head of R&D — this insider has traded ALXN in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $95.66 | 2,520 | $241K | 98.0% |
| 2 | $96.49 | 52 | $5K | 2.0% |
| Total | $95.68 avg | 2,572 | $246K | 100% |
| Filing → |
| SWTX | BUY | 2019-09-19 | $5.0M | — | Filing → |
| ALXN | SELL | 2014-10-28 | $1.1M | — | Filing → |
| ALXN | SELL | 2014-10-07 | $1.7M | — | Filing → |